Loading…
Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells
Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells...
Saved in:
Published in: | ENDOCRINE JOURNAL 1999, Vol.46(6), pp.779-785 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613 |
---|---|
cites | |
container_end_page | 785 |
container_issue | 6 |
container_start_page | 779 |
container_title | ENDOCRINE JOURNAL |
container_volume | 46 |
creator | TSUMORI, MICHIHIRO MURAKAMI, YOSHIO KOSHIMURA, KUNIO KATO, YUZURU |
description | Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells. Inhibiting NOS with NG-nitro-L-arginine or trapping NO with oxyhemoglobin enhanced both the basal and TRH-stimulated rat GH release. Sodium nitroprusside did not further decrease either the basal or the TRH-stimulated GH secretion, suggesting that endogenous NO exerted the maximal inhibitory effect. Inhibition of de novo synthesis of THB increased GH secretion. A cyclic guanosine-monophosphate (cGMP) antagonist did not increase the basal GH secretion but enhanced TRH-induced GH release. These findings suggest that endogenous NO plays an inhibitory role on basal GH release and TRH-stimulated hormone release from GH3 cells in an autocrine or paracrine fashion, at least partly, through a cGMP-dependent pathway. It is also suggested that endogenous THB plays a role in NO production and subsequent inhibition of hormone secretion in GH3 cells. |
doi_str_mv | 10.1507/endocrj.46.779 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1507_endocrj_46_779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10724353</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613</originalsourceid><addsrcrecordid>eNpNkM1u3CAUhVHUKpmk3XZZ8QKegvkzy2qaeCIlzaLtGmEGjxl5wAWsNts8eZg6ibq5d8E5H_ccAD5htMYMiS_W74KJhzXlayHkGVhhQpuKMoregRWSuKkayeQFuEzpgBAhjJJzcIGRqClhZAWergtgb32YE_zucnQGPvx1Owtv_eA6lxNsY_iTB7gN8Ri8hT-siTa74GEeYpj3A9w8mrHY2ln7kFyR3AcfpiGkadDZVt_sVI60PsN7awbtXTom6DxstwRu7DimD-B9r8dkP77sK_Dr5vrnZlvdPbS3m693lSlpZEVRx5nlTOIec400QbXWkvDa0o4KgRHjWHIj-h2XojZSsl4zSTpBqZacY3IF1gvXxJBStL2aojvq-KgwUqcy1UuZinJVyiyGz4thmruj3f0nX9orgptFUF6d0WPwY8mvDmGOviRR5jf_h1RYSqkQohzxsphCBV9Gw5q6aSgroHYBHVLWe_v2k47ZmdG-HlYw5HQcX8YJ8qoozcYiI88s8qJJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells</title><source>J-STAGE Free Content</source><creator>TSUMORI, MICHIHIRO ; MURAKAMI, YOSHIO ; KOSHIMURA, KUNIO ; KATO, YUZURU</creator><creatorcontrib>TSUMORI, MICHIHIRO ; MURAKAMI, YOSHIO ; KOSHIMURA, KUNIO ; KATO, YUZURU ; First Division ; Department of Medicine ; Shimane Medical University</creatorcontrib><description>Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells. Inhibiting NOS with NG-nitro-L-arginine or trapping NO with oxyhemoglobin enhanced both the basal and TRH-stimulated rat GH release. Sodium nitroprusside did not further decrease either the basal or the TRH-stimulated GH secretion, suggesting that endogenous NO exerted the maximal inhibitory effect. Inhibition of de novo synthesis of THB increased GH secretion. A cyclic guanosine-monophosphate (cGMP) antagonist did not increase the basal GH secretion but enhanced TRH-induced GH release. These findings suggest that endogenous NO plays an inhibitory role on basal GH release and TRH-stimulated hormone release from GH3 cells in an autocrine or paracrine fashion, at least partly, through a cGMP-dependent pathway. It is also suggested that endogenous THB plays a role in NO production and subsequent inhibition of hormone secretion in GH3 cells.</description><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.46.779</identifier><identifier>PMID: 10724353</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Animals ; Biopterins - analogs & derivatives ; Biopterins - physiology ; Cell Line ; Cyclic GMP ; Cyclic GMP - analogs & derivatives ; Cyclic GMP - antagonists & inhibitors ; Cyclic GMP - pharmacology ; Cyclic GMP - physiology ; Dose-Response Relationship, Drug ; Drug Synergism ; Enzyme Inhibitors - pharmacology ; GH3 cells ; Growth Hormone - metabolism ; Nitric oxide ; Nitric Oxide - physiology ; Oxyhemoglobins - pharmacology ; Rats ; Tetrahydrobiopterin ; Thionucleotides - pharmacology ; Thyrotropin-Releasing Hormone - pharmacology</subject><ispartof>Endocrine Journal, 1999, Vol.46(6), pp.779-785</ispartof><rights>The Japan Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1882,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10724353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TSUMORI, MICHIHIRO</creatorcontrib><creatorcontrib>MURAKAMI, YOSHIO</creatorcontrib><creatorcontrib>KOSHIMURA, KUNIO</creatorcontrib><creatorcontrib>KATO, YUZURU</creatorcontrib><creatorcontrib>First Division</creatorcontrib><creatorcontrib>Department of Medicine</creatorcontrib><creatorcontrib>Shimane Medical University</creatorcontrib><title>Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells</title><title>ENDOCRINE JOURNAL</title><addtitle>Endocr J</addtitle><description>Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells. Inhibiting NOS with NG-nitro-L-arginine or trapping NO with oxyhemoglobin enhanced both the basal and TRH-stimulated rat GH release. Sodium nitroprusside did not further decrease either the basal or the TRH-stimulated GH secretion, suggesting that endogenous NO exerted the maximal inhibitory effect. Inhibition of de novo synthesis of THB increased GH secretion. A cyclic guanosine-monophosphate (cGMP) antagonist did not increase the basal GH secretion but enhanced TRH-induced GH release. These findings suggest that endogenous NO plays an inhibitory role on basal GH release and TRH-stimulated hormone release from GH3 cells in an autocrine or paracrine fashion, at least partly, through a cGMP-dependent pathway. It is also suggested that endogenous THB plays a role in NO production and subsequent inhibition of hormone secretion in GH3 cells.</description><subject>Animals</subject><subject>Biopterins - analogs & derivatives</subject><subject>Biopterins - physiology</subject><subject>Cell Line</subject><subject>Cyclic GMP</subject><subject>Cyclic GMP - analogs & derivatives</subject><subject>Cyclic GMP - antagonists & inhibitors</subject><subject>Cyclic GMP - pharmacology</subject><subject>Cyclic GMP - physiology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Synergism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>GH3 cells</subject><subject>Growth Hormone - metabolism</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - physiology</subject><subject>Oxyhemoglobins - pharmacology</subject><subject>Rats</subject><subject>Tetrahydrobiopterin</subject><subject>Thionucleotides - pharmacology</subject><subject>Thyrotropin-Releasing Hormone - pharmacology</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpNkM1u3CAUhVHUKpmk3XZZ8QKegvkzy2qaeCIlzaLtGmEGjxl5wAWsNts8eZg6ibq5d8E5H_ccAD5htMYMiS_W74KJhzXlayHkGVhhQpuKMoregRWSuKkayeQFuEzpgBAhjJJzcIGRqClhZAWergtgb32YE_zucnQGPvx1Owtv_eA6lxNsY_iTB7gN8Ri8hT-siTa74GEeYpj3A9w8mrHY2ln7kFyR3AcfpiGkadDZVt_sVI60PsN7awbtXTom6DxstwRu7DimD-B9r8dkP77sK_Dr5vrnZlvdPbS3m693lSlpZEVRx5nlTOIec400QbXWkvDa0o4KgRHjWHIj-h2XojZSsl4zSTpBqZacY3IF1gvXxJBStL2aojvq-KgwUqcy1UuZinJVyiyGz4thmruj3f0nX9orgptFUF6d0WPwY8mvDmGOviRR5jf_h1RYSqkQohzxsphCBV9Gw5q6aSgroHYBHVLWe_v2k47ZmdG-HlYw5HQcX8YJ8qoozcYiI88s8qJJ</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>TSUMORI, MICHIHIRO</creator><creator>MURAKAMI, YOSHIO</creator><creator>KOSHIMURA, KUNIO</creator><creator>KATO, YUZURU</creator><general>The Japan Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1999</creationdate><title>Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells</title><author>TSUMORI, MICHIHIRO ; MURAKAMI, YOSHIO ; KOSHIMURA, KUNIO ; KATO, YUZURU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Biopterins - analogs & derivatives</topic><topic>Biopterins - physiology</topic><topic>Cell Line</topic><topic>Cyclic GMP</topic><topic>Cyclic GMP - analogs & derivatives</topic><topic>Cyclic GMP - antagonists & inhibitors</topic><topic>Cyclic GMP - pharmacology</topic><topic>Cyclic GMP - physiology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Synergism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>GH3 cells</topic><topic>Growth Hormone - metabolism</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - physiology</topic><topic>Oxyhemoglobins - pharmacology</topic><topic>Rats</topic><topic>Tetrahydrobiopterin</topic><topic>Thionucleotides - pharmacology</topic><topic>Thyrotropin-Releasing Hormone - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TSUMORI, MICHIHIRO</creatorcontrib><creatorcontrib>MURAKAMI, YOSHIO</creatorcontrib><creatorcontrib>KOSHIMURA, KUNIO</creatorcontrib><creatorcontrib>KATO, YUZURU</creatorcontrib><creatorcontrib>First Division</creatorcontrib><creatorcontrib>Department of Medicine</creatorcontrib><creatorcontrib>Shimane Medical University</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>ENDOCRINE JOURNAL</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TSUMORI, MICHIHIRO</au><au>MURAKAMI, YOSHIO</au><au>KOSHIMURA, KUNIO</au><au>KATO, YUZURU</au><aucorp>First Division</aucorp><aucorp>Department of Medicine</aucorp><aucorp>Shimane Medical University</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells</atitle><jtitle>ENDOCRINE JOURNAL</jtitle><addtitle>Endocr J</addtitle><date>1999</date><risdate>1999</risdate><volume>46</volume><issue>6</issue><spage>779</spage><epage>785</epage><pages>779-785</pages><issn>0918-8959</issn><eissn>1348-4540</eissn><abstract>Constitutive nitric oxide synthase (NOS) is expressed in rat adenohypophysis and clonal GH3 cells. The mechanisms of action of nitric oxide (NO) to inhibit hormone secretion and the possible role of (6R)-5, 6, 7, 8-tetrahydro-L-biopterin (THB) in the action of endogenous NO were studied in GH3 cells. Inhibiting NOS with NG-nitro-L-arginine or trapping NO with oxyhemoglobin enhanced both the basal and TRH-stimulated rat GH release. Sodium nitroprusside did not further decrease either the basal or the TRH-stimulated GH secretion, suggesting that endogenous NO exerted the maximal inhibitory effect. Inhibition of de novo synthesis of THB increased GH secretion. A cyclic guanosine-monophosphate (cGMP) antagonist did not increase the basal GH secretion but enhanced TRH-induced GH release. These findings suggest that endogenous NO plays an inhibitory role on basal GH release and TRH-stimulated hormone release from GH3 cells in an autocrine or paracrine fashion, at least partly, through a cGMP-dependent pathway. It is also suggested that endogenous THB plays a role in NO production and subsequent inhibition of hormone secretion in GH3 cells.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>10724353</pmid><doi>10.1507/endocrj.46.779</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-8959 |
ispartof | Endocrine Journal, 1999, Vol.46(6), pp.779-785 |
issn | 0918-8959 1348-4540 |
language | eng |
recordid | cdi_crossref_primary_10_1507_endocrj_46_779 |
source | J-STAGE Free Content |
subjects | Animals Biopterins - analogs & derivatives Biopterins - physiology Cell Line Cyclic GMP Cyclic GMP - analogs & derivatives Cyclic GMP - antagonists & inhibitors Cyclic GMP - pharmacology Cyclic GMP - physiology Dose-Response Relationship, Drug Drug Synergism Enzyme Inhibitors - pharmacology GH3 cells Growth Hormone - metabolism Nitric oxide Nitric Oxide - physiology Oxyhemoglobins - pharmacology Rats Tetrahydrobiopterin Thionucleotides - pharmacology Thyrotropin-Releasing Hormone - pharmacology |
title | Endogenous Nitric Oxide Inhibits Growth Hormone Secretion through Cyclic Guanosine Monophosphate-Dependent Mechanisms in GH3 Cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A22%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endogenous%20Nitric%20Oxide%20Inhibits%20Growth%20Hormone%20Secretion%20through%20Cyclic%20Guanosine%20Monophosphate-Dependent%20Mechanisms%20in%20GH3%20Cells&rft.jtitle=ENDOCRINE%20JOURNAL&rft.au=TSUMORI,%20MICHIHIRO&rft.aucorp=First%20Division&rft.date=1999&rft.volume=46&rft.issue=6&rft.spage=779&rft.epage=785&rft.pages=779-785&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.46.779&rft_dat=%3Cpubmed_cross%3E10724353%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5409-40b65e6591f16a0a302aa9362e4b4771056196c7fd6972c995fa593b744a96613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/10724353&rfr_iscdi=true |